Search
for
Sort by
Research 391–420 of 1000+
- Treatment modalities for lymphocytic and neutrophilic scarring alopecia
- Systemic immunotherapies
- 93 Approach to Managing Recalcitrant Alopecia Areata With Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- LB1012 The development of a pediatric alopecia areata treatment classification system based on results from a systematic review
- 013 IL-15/IL-15Rα signaling is a guardian of human hair follicle immune privilege and promotes hair growth
- EE325 Budget Impact of Baricitinib for Patients with Severe Alopecia Areata
- Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata
- Infectious events in patients with alopecia areata treated with JAK inhibitors: low burden and minimal impact on persistence in treatment
- 33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2
- Efficacy and Safety of Ritlecitinib in Alopecia Areata: A Systematic Review and Meta-Analysis (Preprint)
- Evaluating Scarring Alopecia Therapies from the Patient Perspective: Knowledge, Barriers to Care, and Treatment Satisfaction
- Refractory dermatomyositis–systemic lupus erythematosus overlap syndrome and response to tofacitinib
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Evolving treatment paradigms in dermatology: Insights from emerging and repurposed therapies
- Alopecia areata: recognition, diagnosis and management
- DEVELOPING NEW DUAL-ACTION ANTIVIRAL/ANTI-INFLAMMATORY SMALL MOLECULES FOR COVID-19 TREATMENT USING IN SILICO AND IN-VITRO APPROACHES
- The Role of Janus Kinase Inhibitors in Dermatology
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- The role of janus kinases in the treatment of autoimmune skin diseases
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- Tofacitinib in the Management of Alopecia Universalis
- Targeted immunotherapy for hair regrowth and regeneration
- Successful Treatment of Canities Subita with Baricitinib
- Effectiveness and safety of oral Janus kinase inhibitors in patients aged ≤12 with alopecia areata: a systematic review and meta-analysis
- Effectiveness and safety of oral Janus kinase inhibitors in patients aged ≤12 with alopecia areata: a systematic review and meta-analysis
- Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing
- Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise
- The Current State of Patient Adherence to Lab Monitoring Guidelines for Janus Kinase Inhibitors in Patients with Alopecia Areata.
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- Association of Janus kinase inhibitors with reduced depression in alopecia areata